Literature DB >> 21172892

Quality of life after breast cancer diagnosis and survival.

Meira Epplein1, Ying Zheng, Wei Zheng, Zhi Chen, Kai Gu, David Penson, Wei Lu, Xiao-Ou Shu.   

Abstract

PURPOSE: To examine the association of quality of life (QOL) after diagnosis of breast cancer with mortality and recurrence. PATIENTS AND METHODS: From 2002 to 2004, a total of 2,230 breast cancer survivors completed the General Quality of Life Inventory-74 6 months after diagnosis as part of the Shanghai Breast Cancer Survivor Study. Also collected at baseline was information on demographic and clinical characteristics. At 36 months postdiagnosis, 1,845 of these women were re-evaluated for QOL. Outcomes were ascertained by in-person interview and record linkage to the vital statistics registry. The association of QOL with total mortality and cancer recurrence was assessed by using Cox regression analysis.
RESULTS: During a median follow-up of 4.8 years after the 6-month postdiagnosis QOL assessment, 284 deaths were identified. Recurrence was documented in 267 patients after 108 patients with stage IV breast cancer or recurrence before study enrollment were excluded. Women with the highest tertile of social well-being QOL score, compared with those with the lowest score, had a 38% decreased risk of mortality (95% CI, 0.46 to 0.85; P for trend = .002) and a 48% decreased risk of breast cancer recurrence (95% CI, 0.38 to 0.71; P for trend < .001). QOL assessed at 36 months postdiagnosis was not significantly associated with subsequent risk of mortality or recurrence.
CONCLUSION: Social well-being in the first year after cancer diagnosis is a significant prognostic factor for breast cancer recurrence or mortality, suggesting a possible avenue of intervention by maintaining or enhancing social support for women soon after their breast cancer diagnosis to improve disease outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 21172892      PMCID: PMC3058286          DOI: 10.1200/JCO.2010.30.6951

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  33 in total

1.  Baseline health-related quality-of-life data as prognostic factors in a phase III multicentre study of women with metastatic breast cancer.

Authors:  F Efficace; L Biganzoli; M Piccart; C Coens; K Van Steen; T Cufer; R E Coleman; H A Calvert; T Gamucci; C Twelves; P Fargeot; A Bottomley
Journal:  Eur J Cancer       Date:  2004-05       Impact factor: 9.162

2.  Effect of psychosocial treatment on survival of patients with metastatic breast cancer.

Authors:  D Spiegel; J R Bloom; H C Kraemer; E Gottheil
Journal:  Lancet       Date:  1989-10-14       Impact factor: 79.321

3.  The relationship between objective life status and subjective life satisfaction with quality of life.

Authors:  L Li; D Young; H Wei; Y Zhang; Y Zheng; S Xiao; X Wang; X Chen
Journal:  Behav Med       Date:  1998       Impact factor: 3.104

4.  Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.

Authors:  A S Coates; C Hürny; H F Peterson; J Bernhard; M Castiglione-Gertsch; R D Gelber; A Goldhirsch
Journal:  J Clin Oncol       Date:  2000-11-15       Impact factor: 44.544

5.  Health-related quality of life and psychosocial status in breast cancer prognosis: analysis of multiple variables.

Authors:  Pamela J Goodwin; Marguerite Ennis; Louise J Bordeleau; Kathleen I Pritchard; Maureen E Trudeau; Jarley Koo; Nicky Hood
Journal:  J Clin Oncol       Date:  2004-10-15       Impact factor: 44.544

Review 6.  Associations of social networks with cancer mortality: a meta-analysis.

Authors:  Martin Pinquart; Paul R Duberstein
Journal:  Crit Rev Oncol Hematol       Date:  2009-07-14       Impact factor: 6.312

7.  Quality of life and survival prediction in terminal cancer patients: a multicenter study.

Authors:  Antonio Vigano; Nora Donaldson; Irene J Higginson; Eduardo Bruera; Salaheddin Mahmud; Maria Suarez-Almazor
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

8.  Health-related quality of life parameters as prognostic factors in a nonmetastatic breast cancer population: an international multicenter study.

Authors:  Fabio Efficace; Patrick Therasse; Martine J Piccart; Corneel Coens; Kristel van Steen; Marzena Welnicka-Jaskiewicz; Tanja Cufer; Jaroslaw Dyczka; Michail Lichinitser; Lois Shepherd; Hanneke de Haes; Mirjam A Sprangers; Andrew Bottomley
Journal:  J Clin Oncol       Date:  2004-08-15       Impact factor: 44.544

9.  Meta-analysis of the effects of psychosocial interventions on survival time in cancer patients.

Authors:  Geir Smedslund; Gerd Inger Ringdal
Journal:  J Psychosom Res       Date:  2004-08       Impact factor: 3.006

10.  Prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. Australian New Zealand Breast Cancer Trials Group.

Authors:  A Coates; V Gebski; D Signorini; P Murray; D McNeil; M Byrne; J F Forbes
Journal:  J Clin Oncol       Date:  1992-12       Impact factor: 44.544

View more
  58 in total

1.  Benefits of marriage on relative and conditional relative cancer survival differ between males and females in the USA.

Authors:  Ray M Merrill; Erin Johnson
Journal:  J Cancer Surviv       Date:  2017-08-02       Impact factor: 4.442

2.  Enhancing life after cancer in diverse communities.

Authors:  Judith S Kaur; Kathryn Coe; Julia Rowland; Kathryn L Braun; Francisco A Conde; Linda Burhansstipanov; Sue Heiney; Marjorie Kagawa-Singer; Qian Lu; Catherine Witte
Journal:  Cancer       Date:  2012-03-20       Impact factor: 6.860

3.  Social support and socioeconomic status interact to predict Epstein-Barr virus latency in women awaiting diagnosis or newly diagnosed with breast cancer.

Authors:  Christopher P Fagundes; Jeanette M Bennett; Catherine M Alfano; Ronald Glaser; Stephen P Povoski; Adele M Lipari; Doreen M Agnese; Lisa D Yee; William E Carson; William B Farrar; William B Malarkey; Min Chen; Janice K Kiecolt-Glaser
Journal:  Health Psychol       Date:  2011-10-17       Impact factor: 4.267

4.  Randomized controlled trial of Qigong/Tai Chi Easy on cancer-related fatigue in breast cancer survivors.

Authors:  Linda K Larkey; Denise J Roe; Karen L Weihs; Roger Jahnke; Ana Maria Lopez; Carol E Rogers; Byeongsang Oh; Jose Guillen-Rodriguez
Journal:  Ann Behav Med       Date:  2015-04

5.  Trajectories of quality of life following breast cancer diagnosis.

Authors:  Neha G Goyal; Beverly J Levine; Kimberly J Van Zee; Elizabeth Naftalis; Nancy E Avis
Journal:  Breast Cancer Res Treat       Date:  2018-01-24       Impact factor: 4.872

Review 6.  Effects of complementary and integrative medicine on cancer survivorship.

Authors:  Moshe Frenkel; Victor Sierpina; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2015       Impact factor: 5.075

7.  Social well-being is associated with less pro-inflammatory and pro-metastatic leukocyte gene expression in women after surgery for breast cancer.

Authors:  Devika R Jutagir; Bonnie B Blomberg; Charles S Carver; Suzanne C Lechner; Kiara R Timpano; Laura C Bouchard; Lisa M Gudenkauf; Jamie M Jacobs; Alain Diaz; Susan K Lutgendorf; Steve W Cole; Aaron S Heller; Michael H Antoni
Journal:  Breast Cancer Res Treat       Date:  2017-05-30       Impact factor: 4.872

8.  Menopausal symptoms, sexual function, depression, and quality of life in Korean patients with breast cancer receiving chemotherapy.

Authors:  Hyojung Park; Hyeon Gyeong Yoon
Journal:  Support Care Cancer       Date:  2013-04-25       Impact factor: 3.603

9.  EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.

Authors:  Yong Joo Lee; Sang-Yeon Suh; Youn Seon Choi; Jae Yong Shim; Ah-Ram Seo; Sung-Eun Choi; Hong-Yup Ahn; Eunji Yim
Journal:  Support Care Cancer       Date:  2014-03-01       Impact factor: 3.603

10.  Perceived social support change in patients with early stage breast cancer and controls.

Authors:  Tess Thompson; Thomas L Rodebaugh; Maria Pérez; Mario Schootman; Donna B Jeffe
Journal:  Health Psychol       Date:  2013-03-11       Impact factor: 4.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.